Trending Now
Clover Biopharmaceuticals Commences Study On COVID-19 Vaccine Using Dynavax Technologies’ (NASDAQ:DVAX)...
Dynavax Technologies Corporation (NASDAQ:DVAX) has announced that the first subjects have been doses in the first phase clinical study evaluating Clover Biopharmaceuticals' COVID-19 vaccine...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
BigBear.ai Holdings Inc (BBAI) chart shows bullish action
A few days back, BigBear.ai Holdings Inc (BBAI) was trading at just under $2. The stock ran to the middle $2’s prompting...
MAKE IT MODERN
LATEST REVIEWS
Markets turn green post rumors of corona virus treatment availability
Markets are green again this morning on news of more containment of the coronavirus out of China as well as the cutting...
MAKE IT MODERN
PERFORMANCE TRAINING
US DoD Grants Immuron Limited (NASDAQ: IMRN) $4.45 Million Funding For A New...
Immuron Limited (NASDAQ: IMRN) has received $4.45 million in funding from the US Department of Defense (DoD) for a new research agreement.
Immuron receives research...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) Issued Its Shareholders and Investors With an Update...
Mind Medicine (MindMed) Inc (NASDAQ: MNMD) recently declared that Dr Frederike Holze and Dr Matthias Lietchi would be the person to give an update...
Fortress Biotech Inc. (NASDAQ:FBIO) Announce Commencement Of Phase 3 CAEL-101 Studies In AL Amyloidosis
Fortress Biotech Inc. (NASDAQ:FBIO) has announced that Caelum Biosciences Inc., in partnership with Alexion Pharmaceuticals Inc., has commenced the Cardiac Amyloid Reaching for Extended...
Transocean LTD (NYSE: RIG) Reports a Net Loss Attributable to Controlling Interest of $103...
Transocean LTD (NYSE: RIG) recently announced its financial results for the second quarter of 2021. In the report, the company announced a net loss...
Altimmune Inc. (NASDAQ:ALT) Commences T-COVID Clinical Trial For Treatment Of Patients With Onset COVID-19...
Altimmune Inc. (NASDAQ:ALT) has announced that the FDA has given the company a go-ahead to proceed with its T-COVID clinical trial. T-COVID is Altimmune’s...
MAKE IT MODERN
